272 related articles for article (PubMed ID: 6369467)
1. [Results of 2 chemotherapy protocols (VPA and C-VPA) in acute adult lymphoblastic leukemia].
Avilés Miranda A; Ambriz Fernández R; Díaz Maqueo JC; Mascaró Sacristán J; Sinco Angeles A; Pizzuto J
Rev Invest Clin; 1983; 35(4):285-9. PubMed ID: 6369467
[No Abstract] [Full Text] [Related]
2. [Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
Leverger G; Bancillon A; Schaison G
Pathol Biol (Paris); 1987 Jan; 35(1):87-90. PubMed ID: 3550617
[TBL] [Abstract][Full Text] [Related]
3. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
Freeman AI
Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
[No Abstract] [Full Text] [Related]
4. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
[TBL] [Abstract][Full Text] [Related]
5. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
6. Treatment of B-cell non-Hodgkin's malignant lymphomas of childhood in Europe: recent and on-going studies.
Lemerle J
IARC Sci Publ; 1985; (60):383-98. PubMed ID: 3905590
[No Abstract] [Full Text] [Related]
7. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
[No Abstract] [Full Text] [Related]
8. [Therapeutic study VII/81 of the treatment of acute lymphoblastic leukemia in childhood].
Zintl F; Plenert W; Malke H; Blau HJ; Dörffel W; Exadaktylos P; Hofmann K; Korth G; Kotte W; Kuhnert W
Kinderarztl Prax; 1986 Mar; 54(3):141-52. PubMed ID: 3520095
[No Abstract] [Full Text] [Related]
9. [Treatment of acute lymphoblastic leukemia].
Paolucci G; Rosito P
Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
[No Abstract] [Full Text] [Related]
10. [Treatment of acute lymphoblastic leukemia during a remission by irradiation of the central nervous system and subsequent administration of 8 chemotherapeutic agents].
Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Cattan A; Schlumberger JR
Sem Hop; 1966 Nov; 42(49):2960-5. PubMed ID: 4292623
[No Abstract] [Full Text] [Related]
11. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Büyükçelik A; Yalçin B; Utkan G; Doruk H
Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
[No Abstract] [Full Text] [Related]
12. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
[No Abstract] [Full Text] [Related]
13. [Treatment of acute childhood leukemia. A new protocol 811 for the standard risk group of acute lymphocytic leukemia (Phase III study)].
Koizumi S; Fujimoto T; Higashi O; Utsumi J; Mimaya J; Sekine I; Shike S; Imashuku S; Yamamoto S; Ninomiya T
Rinsho Ketsueki; 1983 Dec; 24(12):1633-40. PubMed ID: 6368900
[No Abstract] [Full Text] [Related]
14. [Treatment of acute leukemias].
Gross R; Gerecke D
Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a polychemotherapeutic regimen including Idarubicin (4-demethoxydaunorubicin) in relapsed acute lymphocytic leukemia.
Mandelli F; Testi AM; Aloe Spiriti MA; Giona F; Meloni G; Moleti ML; Amadori S; Pacciarini MA
Haematologica; 1986; 71(1):34-8. PubMed ID: 3084353
[No Abstract] [Full Text] [Related]
16. Influence of intensive induction and consolidation therapy in acute lymphoblastic leukaemia in children.
Sanchetee SC; Pai SK; Pai VR; Kurkure PA; Shetty PA
Indian J Cancer; 1985 Sep; 22(3):217-20. PubMed ID: 3870462
[No Abstract] [Full Text] [Related]
17. Breast cancer 1984: state of the art.
Sledge GW
Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
[No Abstract] [Full Text] [Related]
18. Prospective study of central nervous system changes in children with acute lymphoblastic leukemia receiving two different methods of central nervous system prophylaxis.
Ochs J; Parvey LS; Mulhern R
Neurotoxicology; 1986; 7(2):217-26. PubMed ID: 2431364
[No Abstract] [Full Text] [Related]
19. [Treatment of acute lymphoblastic leukemia in adults using the 08 LA 74 and RALL 81 A protocols].
Colović M; Petrović M; Janković G; Janosević S; Jancić M
Srp Arh Celok Lek; 1988 Mar; 116(3):227-33. PubMed ID: 3166210
[No Abstract] [Full Text] [Related]
20. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
